Jones Collombin Investment Counsel Upped By $5.88 Million Its Bank N S Halifax (BNS) Stake; Iguana Healthcare Management Lifted Its Boston Scientific (BSX) Stake

Jones Collombin Investment Counsel Inc increased Bank N S Halifax (BNS) stake by 501.75% reported in 2017Q3 SEC filing. Jones Collombin Investment Counsel Inc acquired 91,870 shares as Bank N S Halifax (BNS)’s stock declined 10.69%. The Jones Collombin Investment Counsel Inc holds 110,180 shares with $7.09M value, up from 18,310 last quarter. Bank N S Halifax now has $72.02 billion valuation. The stock increased 0.55% or $0.33 during the last trading session, reaching $60.79. About 1.27M shares traded or 96.38% up from the average. The Bank of Nova Scotia (NYSE:BNS) has risen 16.52% since February 12, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Iguana Healthcare Management Llc increased Boston Scientific Corp (BSX) stake by 127.27% reported in 2017Q3 SEC filing. Iguana Healthcare Management Llc acquired 70,000 shares as Boston Scientific Corp (BSX)’s stock rose 4.02%. The Iguana Healthcare Management Llc holds 125,000 shares with $3.65 million value, up from 55,000 last quarter. Boston Scientific Corp now has $35.59 billion valuation. The stock increased 2.86% or $0.72 during the last trading session, reaching $25.92. About 11.07 million shares traded or 12.04% up from the average. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since February 12, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Among 9 analysts covering The Bank Of Nova Scotia (NYSE:BNS), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. The Bank Of Nova Scotia had 17 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, August 29. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, August 31 report. Dundee Securities initiated the shares of BNS in report on Wednesday, September 21 with “Buy” rating. The stock has “Neutral” rating by Macquarie Research on Thursday, June 9. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, December 2. The firm has “Outperform” rating given on Wednesday, May 31 by RBC Capital Markets. Canaccord Genuity maintained the stock with “Buy” rating in Friday, August 28 report. The firm earned “Outperform” rating on Monday, August 31 by RBC Capital Markets. The firm has “Overweight” rating by Barclays Capital given on Tuesday, May 23.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 89 analyst reports since July 27, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, October 11 by BMO Capital Markets. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Neutral” rating by Wedbush on Thursday, April 28. The rating was upgraded by Goldman Sachs to “Neutral” on Thursday, August 27. The rating was maintained by Cowen & Co on Thursday, July 27 with “Buy”. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Wednesday, June 28 by Barclays Capital. Needham maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, July 29. Needham has “Buy” rating and $28 target. As per Monday, July 10, the company rating was maintained by RBC Capital Markets. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Hold” rating by Oppenheimer on Wednesday, June 28. On Monday, June 19 the stock rating was maintained by BMO Capital Markets with “Buy”. Stifel Nicolaus maintained the shares of BSX in report on Tuesday, August 1 with “Buy” rating.

Since August 29, 2017, it had 0 insider buys, and 12 selling transactions for $16.75 million activity. $139,104 worth of stock was sold by Pierce David A on Tuesday, January 9. 11,061 shares valued at $323,435 were sold by Pratt Timothy A. on Monday, October 2. Fitzgerald Joseph Michael sold 85,227 shares worth $2.26M. The insider Phalen Michael P. sold $399,865. 347,137 shares were sold by Bose Supratim, worth $10.11 million on Tuesday, October 3. Nanavaty Maulik sold 57,031 shares worth $1.56 million.